The Simvastatin Study Protocol

The Simvastatin Study Protocol
This week researchers from the University of Plymouth published the study protocol of the ongoing PD STAT clinical trial, which is evaluating the disease modifying potential of the cholesterol-lowering drug simvastatin in 230 people with Parkinson's. This is yet another example of CPT's clinical study testing a re-purposed medication for Parkinson's within the Linked Clinical Trials initiative. Simvastatin belongs to ... read more
Source: The Cure Parkinson’s TrustPublished on 2019-10-10